340B Coalition Conference Keynote: Program Faces Rebate Threats, Data Demands and ‘Organized Misinformation Campaign’
The 340B program is facing mounting pressures from possible 340B rebates, new drugmaker data demands, federal policy uncertainty and an [...]

